Literature DB >> 8683979

Effect of methylglyoxal on human leukaemia 60 cell growth: modification of DNA G1 growth arrest and induction of apoptosis.

Y Kang1, L G Edwards, P J Thornalley.   

Abstract

Methylglyoxal induced growth arrest in the G1 phase of the cell cycle and toxicity in human leukaemia 60 cells in vitro. Inhibition of DNA synthesis but not inhibition of RNA synthesis, protein synthesis or inhibition of glyceraldehyde-3-phosphate dehydrogenase activity correlated with cytotoxicity. Incubation of human leukaemia 60 cells with methylglyoxal led to the rapid accumulation of adducts of methylglyoxal with DNA, and a lower accumulation of methylglyoxal adducts with RNA and protein in the initial hour of culture; fragmentation of nuclear DNA characteristic of apoptosis developed in the second hour of culture. Methylglyoxal induced apoptosis in human leukaemia 60 cells but did not affect the growth and viability of concanavalin A-stimulated human peripheral lymphocytes in vitro. These effects confirm and further substantiate the anti-proliferative anti-tumour activity of methylglyoxal in vitro, which may mediate the anti-tumour activity of glyoxalase I inhibitors in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683979     DOI: 10.1016/0145-2126(95)00162-x

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  34 in total

1.  Toxic concentrations of exogenously supplied methylglyoxal in hybridoma cell culture.

Authors:  Benjamin M Roy; Tiffany D Rau; R Robert Balcarcel
Journal:  Cytotechnology       Date:  2005-11-30       Impact factor: 2.058

2.  New Arabidopsis thaliana cytochrome c partners: a look into the elusive role of cytochrome c in programmed cell death in plants.

Authors:  Jonathan Martínez-Fábregas; Irene Díaz-Moreno; Katiuska González-Arzola; Simon Janocha; José A Navarro; Manuel Hervás; Rita Bernhardt; Antonio Díaz-Quintana; Miguel Á De la Rosa
Journal:  Mol Cell Proteomics       Date:  2013-09-09       Impact factor: 5.911

3.  Glo1 genetic amplification as a potential therapeutic target in hepatocellular carcinoma.

Authors:  Shirong Zhang; Xiaodong Liang; Xiaoliang Zheng; Haixiu Huang; Xufeng Chen; Kan Wu; Bing Wang; Shenglin Ma
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

4.  Methylglyoxal suppresses human colon cancer cell lines and tumor growth in a mouse model by impairing glycolytic metabolism of cancer cells associated with down-regulation of c-Myc expression.

Authors:  Tiantian He; Huaibin Zhou; Chunmei Li; Yuan Chen; Xiaowan Chen; Chenli Li; Jiating Mao; Jianxin Lyu; Qing H Meng
Journal:  Cancer Biol Ther       Date:  2016-07-25       Impact factor: 4.742

Review 5.  Methylglyoxal, obesity, and diabetes.

Authors:  Paulo Matafome; Cristina Sena; Raquel Seiça
Journal:  Endocrine       Date:  2012-09-16       Impact factor: 3.633

6.  Potent apoptosis-inducing activity of erypoegin K, an isoflavone isolated from Erythrina poeppigiana, against human leukemia HL-60 cells.

Authors:  Kiyomi Hikita; Natsuki Hattori; Aya Takeda; Yuko Yamakage; Rina Shibata; Saori Yamada; Kuniki Kato; Tomiyasu Murata; Hitoshi Tanaka; Norio Kaneda
Journal:  J Nat Med       Date:  2017-11-18       Impact factor: 2.343

7.  Activity of the Yap1 transcription factor in Saccharomyces cerevisiae is modulated by methylglyoxal, a metabolite derived from glycolysis.

Authors:  Kazuhiro Maeta; Shingo Izawa; Shoko Okazaki; Shusuke Kuge; Yoshiharu Inoue
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

8.  Transcriptomic response of Enterococcus faecalis V583 to low hydrogen peroxide levels.

Authors:  Xue Yan; Aurélie Budin-Verneuil; Nicolas Verneuil; Michael S Gilmore; Sébastien Artigaud; Yanick Auffray; Vianney Pichereau
Journal:  Curr Microbiol       Date:  2014-09-23       Impact factor: 2.188

Review 9.  Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease.

Authors:  Paul J Thornalley
Journal:  Drug Metabol Drug Interact       Date:  2008

10.  Glyoxalase 1 and protein kinase Cλ as potential therapeutic targets for late-stage breast cancer.

Authors:  Hitomi Motomura; Ayaka Ozaki; Shoma Tamori; Chotaro Onaga; Yuka Nozaki; Yuko Waki; Ryoko Takasawa; Kazumi Yoshizawa; Yasunari Mano; Tsugumichi Sato; Kazunori Sasaki; Hitoshi Ishiguro; Yohei Miyagi; Yoji Nagashima; Kouji Yamamoto; Keiko Sato; Takehisa Hanawa; Sei-Ichi Tanuma; Shigeo Ohno; Kazunori Akimoto
Journal:  Oncol Lett       Date:  2021-05-24       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.